Jim Cramer on Roche's InterMune Acquisition - Presented by: The Aol. On Network

Jim Cramer says Roche's $8.3 billion bid for U.S. biotech firm InterMune means big pharma is thinking big. Cramer says there are so many biotech companies out there losing money as InterMune was, while at the same time companies like Roche, Merck, Pfizer and Glaxo need to make acquisitions for growth.

Related Videos

Most Popular Videos

Latest Videos